Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,721–2,728 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Merck & Company Inc. ODM-208 - (CYPIDES) Metastatic Castration-Resistant Prostate (mCRPC) Cancer Phase 2 oral Oncology
Merck & Company Inc. MK-2060 End-stage renal disease (ESRD) patients receiving hemodialysis Phase 2 Intravenous N/A
Merck & Company Inc. NKTR-255 with BAVENCIO (avelumab) - (JAVELIN) Locally advanced or metastatic urothelial carcinoma (UC) Phase 2 Data Released Intravenous Oncology
Merck & Company Inc. REBLOZYL (Luspatercept) - (COMMANDS) Non-transfusion-dependent beta-thalassemia Phase 2 Data Released Subcutaneous injection Genetic Disorder
Merck & Company Inc. REBLOZYL (Luspatercept) - (COMMANDS) Non-transfusion-dependent beta-thalassemia Phase 2 Data Released Subcutaneous injection Genetic Disorder
Merck & Company Inc. MRx0518 with bavencio (avelumab) 1L Urothelial carcinoma Phase 2 Intravenous Oncology
Merck & Company Inc. INT230-6 with Keytruda Pancreatic, Colon, Bile Duct and Squamous Cell Cancer Phase 2 intratumoral and intravenous Oncology
Merck & Company Inc. PRA023 - (ATHENA-SSc-ILD) Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) Phase 2 Ongoing Intravenous Respiratory